Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related DonorsJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Bone Marrow Transplantation|January 26, 2019
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamideJacopo Mariotti, Angela Granata, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamideLuca Castagna, Roberto Crocchiolo, Sabine Furst, et al.
Hematology, Transfusion and Cell Therapy|July 30, 2026
Rapid genomic analysis for early identification of complement abnormalities in adults with transplant-associated thrombotic microangiopathyJacopo Mariotti, Stefania Bramanti, Luigi Porcaro, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 25, 2015
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamideJean El-Cheikh, Roberto Crocchiolo, Andrea Vai, et al.
Transplantation and Cellular Therapy|April 10, 2021
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis LymphomasLuca Castagna, Anna Dodero, Francesca Patriarca, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning RegimenAnna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Frontiers in Immunology|January 25, 2024
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivationClara Di Vito, Nicolò Coianiz, Michela Calvi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Pageof 7